|
|
|
Volumn 3, Issue 3, 2002, Pages 365-373
|
|
Development of WF10, a novel macrophage-regulating agent
a
|
|
Author keywords
HIV; Inflammation; Macrophage; T cell; WF10
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD14 ANTIGEN;
CD20 ANTIGEN;
CD28 ANTIGEN;
CD3 ANTIGEN;
CD38 ANTIGEN;
CD4 ANTIGEN;
CD56 ANTIGEN;
CD8 ANTIGEN;
CYTOKINE;
OXO K 993;
PLACEBO;
PROTEINASE INHIBITOR;
SODIUM CHLORITE;
TETRACHLORODECAOXIDE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANEMIA;
ASIA;
ASTHENIA;
AUTOIMMUNE DISEASE;
CHRONIC ACTIVE HEPATITIS;
CLINICAL TRIAL;
CYSTITIS;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERABILITY;
EUROPE;
GENE ACTIVATION;
GENE EXPRESSION;
HEADACHE;
HEPATITIS C;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IN VITRO STUDY;
IN VIVO STUDY;
LEUKOCYTOSIS;
MACROPHAGE FUNCTION;
MORTALITY;
NAUSEA;
NONHUMAN;
PHAGOCYTOSIS;
PHARMACODYNAMICS;
PHOTOPHOBIA;
PROSTATE CANCER;
REVIEW;
SIDE EFFECT;
T LYMPHOCYTE;
TASTE AVERSION;
UNITED STATES;
VERTIGO;
VIRUS INHIBITION;
VIRUS LOAD;
VIRUS MUTATION;
VIRUS REPLICATION;
CHLORINE;
CLINICAL TRIALS, PHASE III;
DRUG APPROVAL;
GENE EXPRESSION;
HIV INFECTIONS;
HUMANS;
IMMUNITY, CELLULAR;
LEGISLATION, DRUG;
MACROPHAGE ACTIVATION;
MACROPHAGES;
OXIDES;
UNITED STATES;
|
|
EID: 0036231410
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (25)
|
|
References (36)
|
